Rituximab-ameliorated Cutaneous Extravascular Necrotizing Granuloma

Intern Med. 2024 May 1;63(9):1333-1334. doi: 10.2169/internalmedicine.2313-23. Epub 2023 Sep 1.

Authors

Naoya Oka^{1

2}, Yusuke Yoshida¹, Manami Sueoka^{3

4}, Shintaro Hirata¹

Affiliations

¹ Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan.
² Department of Rheumatology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Japan.
³ Department of Dermatology, Hiroshima University Hospital, Japan.
⁴ Department of Dermatology, Hiroshima-Nishi Medical Center, Japan.

PMID: 37661449
DOI: 10.2169/internalmedicine.2313-23

No abstract available

Keywords: ANCA; granuloma; mepolizumab; rituximab.

Publication types

Case Reports

MeSH terms

Female
Granuloma* / diagnostic imaging
Granuloma* / drug therapy
Granuloma* / pathology
Humans
Male
Middle Aged
Necrosis
Rituximab* / therapeutic use
Skin Diseases / drug therapy
Skin Diseases / pathology

Substances

Rituximab